ASTRAZENECA PLC DL-,25/ GB0009895292 /
2024-06-06 8:08:12 AM | Chg. -0.15 | Volume | Bid8:59:31 PM | Ask8:59:31 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
146.60EUR | -0.10% | 0 Turnover: 0.00 |
148.05Bid Size: 40 | 148.50Ask Size: 40 | 228.94 bill.EUR | - | - |
GlobeNewswire
3:00 PM
Sermonix Pharmaceuticals Announces Chinese Approval of Investigational New Drug Application for Laso...
GlobeNewswire
05-08
Annual NMDP Gala in New York Raises More Than $560,000, Enabling More Patients to Receive Life-Savin...
GlobeNewswire
05-06
Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca
GlobeNewswire
05-02
Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant R...
GlobeNewswire
03-28
HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Pati...